Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Fortún J, Ruiz I, Martín-Dávila P, Cuenca-Estrella M.

    Fungal infection in solid organ recipients.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 30 Suppl 2: 49-56.

    [doi:10.1016/S0213-005X(12)70082-4]

  • Pérez-Molina JA, Díaz-Menéndez M, Plana MN, Zamora J, López-Vélez R, Moreno S.

    Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials

    The Journal of antimicrobial chemotherapy . 67(2): 312-321. Nº de citas: 15

    [doi:10.1093/jac/dkr478]

  • Pineda JA, Neukam K, Mallolas J, López-Cortés LF, Cartón JA, Domingo P, Moreno S, Iribarren JA, Clotet B, Crespo M, de Los Santos I, Ortega E, Knobel H, Jiménez-Expósito MJ, Macías J.

    Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis

    JOURNAL OF INFECTION . 64(2): 204-211. Nº de citas: 7

    [doi:10.1016/j.jinf.2011.10.016]

  • Fernàndez-Sabé N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M, Torre-Cisneros J, Martín-Dávila P, Noblejas A, Len O, García-Reyne A, Del Pozo JL, Carratalà J.

    Risk Factors, Clinical Features, and Outcomes of Toxoplasmosis in Solid-Organ Transplant Recipients: A Matched Case-Control Study

    CLINICAL INFECTIOUS DISEASES . 54(3): 355-361. Nº de citas: 80

    [doi:10.1093/cid/cir806]

  • Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A.

    Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

    JOURNAL OF CLINICAL MICROBIOLOGY . 50(2): 407-413. Nº de citas: 34

    [doi:10.1128/JCM.05798-11]

  • Kowalska JD, Reekie J, Mocroft A, Reiss P, Ledergerber B, Gatell J, d'Arminio Monforte A, Phillips A, Lundgren JD, Kirk O, EuroSIDA study group.

    Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy

    AIDS . 26(3): 315-323. Nº de citas: 26

    [doi:10.1097/QAD.0b013e32834e8805]

  • Tejada Evans AD, Ortega-Sánchez G, Moreno Guillén S.

    Síndrome de coloración púrpura de la orina.

    REVISTA CLINICA ESPANOLA . 212(1): .

    [doi:10.1016/j.rce.2011.11.002]

  • Mocroft A, Bannister WP, Kirk O, Kowalska JD, Reiss P, D'Arminio-Monforte A, Gatell J, Fisher M, Trocha H, Rakhmanova A, Lundgren JD.

    The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression

    ANTIVIRAL THERAPY . 17(7): 1291-1300. Nº de citas: 6

    [doi:10.3851/IMP2407]

  • Jarrin I, Pantazis N, Gill MJ, Geskus R, Perez-Hoyos S, Meyer L, Prins M, Touloumi G, Johnson A, Hamouda O, de Olalla PG, Porter K, del Amo J.

    Uptake of Combination Antiretroviral Therapy and HIV Disease Progression According to Geographical Origin in Seroconverters in Europe, Canada, and Australia

    CLINICAL INFECTIOUS DISEASES . 54(1): 111-118. Nº de citas: 15

    [doi:10.1093/cid/cir814]

  • Molina JM, Lamarca A, Andrade-Villanueva J, Clotet B, Clumeck N, Liu YP, Zhong L, Margot N, Cheng AK, Chuck SL, Study 145 Team.

    Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

    LANCET INFECTIOUS DISEASES . 12(1): 27-35. Nº de citas: 138

    [doi:10.1016/S1473-3099(11)70249-3]

  • Monge-Maillo B, López-Vélez R.

    Migration and malaria in europe.

    Mediterranean journal of hematology and infectious diseases . 4(1): .

    [doi:10.4084/MJHID.2012.014]

  • Díaz-Menéndez M, Pérez-Molina JA, Norman FF, Pérez-Ayala A, Monge-Maillo B, Fuertes PZ, López-Vélez R.

    Management and Outcome of Cardiac and Endovascular Cystic Echinococcosis

    PLOS NEGLECTED TROPICAL DISEASES . 6(1): . Nº de citas: 19

    [doi:10.1371/journal.pntd.0001437]

  • Pintado V, Pazos R, Jiménez-Mejías ME, Rodríguez-Guardado A, Gil A, García-Lechuz JM, Cabellos C, Chaves F, Domingo P, Ramos A, Pérez-Cecilia E, Domingo D.

    Methicillin-Resistant Staphylococcus aureus Meningitis in Adults A Multicenter Study of 86 Cases

    Medicine . 91(1): 10-17. Nº de citas: 19

    [doi:10.1097/MD.0b013e318243442b]

  • Moreno A, Cervera C, Fortún J, Blanes M, Montejo E, Abradelo M, Len O, Rafecas A, Martín-Davila P, Torre-Cisneros J, Salcedo M, Cordero E, Lozano R, Pérez I, Rimola A, Miró JM.

    Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis c virus-coinfected liver transplant recipients: A FIPSE/GESIDA Prospective Cohort Study

    LIVER TRANSPLANTATION . 18(1): 70-82. Nº de citas: 33

    [doi:10.1002/lt.22431]

  • Cordero E, Pérez-Romero P, Moreno A, Len O, Montejo M, Vidal E, Martín-Dávila P, Fariñas MC, Fernández-Sabé N, Giannella M, Pachón J.

    Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 18(1): 67-73. Nº de citas: 46

    [doi:10.1111/j.1469-0691.2011.03537.x]

  • Sobrino-Vegas P, Pérez-Hoyos S, Geskus R, Padilla B, Segura F, Rubio R, Del Romero J, Santos J, Moreno S, Del Amo J.

    Imputation of the Date of HIV Seroconversion in a Cohort of Seroprevalent Subjects: Implications for Analysis of Late HIV Diagnosis.

    AIDS research and treatment . 2012: 725412-725412.

    [doi:10.1155/2012/725412]

  • Sobrino-Vegas P, Rodríguez-Urrego J, Berenguer J, Caro-Murillo AM, Blanco JR, Viciana P, Moreno S, Bernardino I, del Amo J.

    Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

    ANTIVIRAL THERAPY . 17(1): 1-8. Nº de citas: 41

    [doi:10.3851/IMP1939]

  • Tamarit Mdel P, Quereda C, Gonzalez-Rozas M, Corral I, Casado JL.

    HIV Type 1 Viral Encephalitis After Development of Viral Resistance to Plasma Suppressive Antiretroviral Therapy

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 28(1): 83-86. Nº de citas: 19

    [doi:10.1089/aid.2011.0020]